Kingboard Holdings stock
0148.HKHKSEKingboard Holdings Limited, Basic MaterialsISIN KYG525621408
51Score 51 out of 100, Neutral
Price and trend
35 / 100
Price history
+50% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 22% below it.
Since November 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 42).
The price is 71% below its 52-week high. Largest decline in 20 years: 83% (October 2007 to October 2008).
Chart figures for advanced users
- SMA 50$6.50
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$6.71
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)42
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$3.21
- The lowest closing price of the last twelve months.
- Resistance$17.98
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Kingboard Holdings Limited belongs to the Chemicals (Specialty) industry (Hong Kong SAR China) and, with a market value of $5.89B, is number 53 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $5.78B (up 5.3% year on year) and earnings of $561.03M (up 170%).
- For fiscal 2026, analysts expect on average revenue of $7.58B (up 31%) and adjusted earnings per share of $1.03 (up 103.6%).
Show more
- MEQIRI Score 51 out of 100 (Neutral): rank 308 of 467 in Basic Materials, median 58.
- The P/E is 10.2 (Chemicals (Specialty) median 20.2, own median of recent years 7.6).
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Analysts expect strong earnings growthUp 32.3% a year through 2027 (estimates from 2 analysts).
- High dividend yieldDividend yield 5.15%, Chemicals (Specialty) median 0.89%.
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 68
Weaknesses
- Margin fallingOperating margin 9.2%, average of the prior years 17.5% (to 2024).Profitability 46
- Volatile share priceVolatility 79% a year over the last 12 months.Stability 62
Its standout strength is valuation, while technical analysis and growth hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Possible value trapClosing price of 11 Nov 2026, used by the daily score.
A fair value is not meaningful here, so the signal follows the valuation grade.
Possible value trap: looks cheap, but weak growth.
Valuation metrics
The model puts the fair value at more than four times the share price. That says more about the assumptions than about the company, so a fair value is not meaningful here and the valuation relies on the P/E and the other metrics.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Jun 2026, revenue rose 19.4% on the twelve months before. Revenue has grown solidly since 2006, at about 5% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 17%, operating 9%, net 10%.
Debt & balance sheet
latest quarterModerate debt, and interest is adequately covered.
Earnings
- Next earnings
- 22 Mar 2027in 130 days
- Last reported
- 24 Aug 2026EPS reported $0.31
Analyst estimates
Earnings estimates have barely changed since 25 Oct 2026.
- Earnings per share
- $1.030.0%
- Revenue
- $7.58B0.0%
- Earnings per share
- $1.150.0%
- Revenue
- $8.85B0.0%
MEQIRI has stored the estimates since 25 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Kingboard Holdings
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 51
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Fuchs PetrolubFPE3.DE $6.34B74
- Shandong Sinocera Functional Material300285.SZ $6.23B55
- Linde IndiaLINDEINDIA.NS $6.21B63
- Shenzhen Capchem Technology300037.SZ $6.12B63
- Berger Paints IndiaBERGEPAINT.NS $5.93B68
- Inner Mongolia Junzheng Energy & Chemical Group601216.SS $5.87B52
- Gujarat FluorochemicalsFLUOROCHEM.NS $5.66B59
- Hubei Feilihua Quartz Glass300395.SZ $5.58B55
ETFs that hold Kingboard Holdings
Held by 40 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Deka MSCI China ex A Shares UCITS ETFEL46 | 0.26% | 0.65% | €74.12M |
| Xtrackers MSCI China UCITS ETF 1CXCS6 | 0.18% | 0.65% | €1.51B |
| Franklin FTSE China UCITS ETFFLXC | 0.14% | 0.19% | €1.3B |
Show 5 more
| L&G Asia Pacific ex Japan Equity UCITS ETFETLK | 0.12% | 0.10% | €693.62M |
| Avantis Emerging Markets Equity UCITS ETF USD AccAVEM | 0.11% | 0.35% | €277.45M |
| State Street SPDR MSCI EM Asia UCITS ETF Accum USDSPYA | 0.05% | 0.55% | €1.3B |
| iShares MSCI AC Far East ex-Japan UCITS ETFIQQF | 0.05% | 0.74% | €1.34B |
| Vanguard FTSE Emerging Markets UCITS ETF (USD) AccumulatingVFEA | 0.05% | 0.17% | €5.24B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = HK$7.8456)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 25 Apr 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.